Overview
Commence transforms unstructured health data from sources like medical records, claims, and clinical notes into structured, AI-ready data to support decision making. Its flagship Amplify platform combines Capture (digitize and standardize records), Review (AI-classified and summarized clinical data), and Clarity (patterns and risks) to create reusable workflows that can be used separately or together. The company differentiates itself by pairing this data work with expert oversight from over 500 licensed clinicians and serving a mix of federal health agencies (CMS, VA, DHA), state/local governments, and commercial partners. Its goal is to improve healthcare outcomes by turning data into actionable insights through an interoperable data-to-decision platform.
Work here?Claim your company
Simplify's take
What believers are saying
- September 2026 brought Greg Davis, strengthening federal sales execution and capture.
- Commence won CMS RMADA 3 placement and new VA, DHA modernization awards.
- The company serves 60% of Medicare patients across 27 states, creating scale advantages.
What critics are saying
- Federal budget and policy changes already delayed Commence’s growth plans in 2025.
- Heavy CMS, VA, and DHA exposure ties revenue to federal procurement cycles.
- AI health-data rivals like Cotiviti and Optum push deeper into reviews and program integrity.
What makes Commence unique
- May 2025 merger joined DOMA, Livanta, and Advanta into one federal-health platform.
- Amplify launched July 2025, unifying Capture, Review, and Clarity for health-data workflows.
- Over 500 licensed clinicians add human review to AI-driven medical record transformation.
Help us improve and share your feedback! Did you find this helpful?